Comparison of Rhabdomyolysis Markers in Patients Undergoing Bariatric Surgery with Propofol and Inhalation-based Anesthesia

Obesity Surgery

Volumn 25, Issue 10, 2015, Pages 1923-1927

  Lehavi, Amit ^a,c   Sandler, Olga ^a   Mahajna, Ahmad ^a   Weissman, Abraham ^a   Katz, Yeshayahu Shai ^a,b  

^a Rambam Healthcare Campus ^*  (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bariatric surgery; PRIS; Propofol; Propofol infusion syndrome; Rhabdomyolysis; Sleeve gastrectomy

Indexed keywords

BICARBONATE; BIOLOGICAL MARKER; CREATINE KINASE; CREATININE; PROPOFOL; SEVOFLURANE; TROPONIN I; UREA; INTRAVENOUS ANESTHETIC AGENT;

ADULT; AGE; ALKALOSIS; ANESTHESIA COMPLICATION; ANESTHESIA LEVEL; ARTICLE; BARIATRIC SURGERY; BISPECTRAL INDEX; BLOOD GAS ANALYSIS; BLOOD TRANSFUSION; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; DRUG EFFECT; FEMALE; GENDER; GENERAL ANESTHESIA; HEART INJURY; HEIGHT; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; MALE; MORBID OBESITY; MUSCLE NECROSIS; PATIENT; PH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY ACIDOSIS; RHABDOMYOLYSIS; SLEEVE GASTRECTOMY; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VENOUS BLOOD; WEIGHT; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; COMPLICATION; GASTRECTOMY; INHALATION ANESTHESIA; LAPAROSCOPY; MIDDLE AGED; OBESITY, MORBID; PILOT STUDY;

ADULT; ANESTHESIA, INHALATION; ANESTHETICS, INTRAVENOUS; BARIATRIC SURGERY; BIOMARKERS; FEMALE; GASTRECTOMY; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PILOT PROJECTS; PROPOFOL; RHABDOMYOLYSIS;

EID: 84940954962     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1626-6     Document Type: Article

References (22)

1. Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol. 2009;75(5):339–44.
2. Ramaiah R, Lollo L, Brannan D, et al. Propofol infusion syndrome in a super morbidly obese patient (BMI = 75). Int J Crit Illn Inj Sci. 2011;1(1):84–6. doi:10.4103/2229-5151.79290.
3. Diaz JH, Roberts CA, Oliver JJ, et al. Propofol infusion syndrome or not? A case report. Ochsner J. 2014;14(3):434–7.
4. Torres-Villalobos G, Kimura E, Mosqueda JL, et al. Pressure-induced rhabdomyolysis after bariatric surgery. Obes Surg. 2003;13(2):297–301. doi:10.1381/096089203764467252.
5. Bostanjian D, Anthone GJ, Hamoui N, et al. Rhabdomyolysis of gluteal muscles leading to renal failure: a potentially fatal complication of surgery in the morbidly obese. Obes Surg. 2003;13(2):302–5. doi:10.1381/096089203764467261.
6. Chakravartty S, Sarma DR, Patel AG. Rhabdomyolysis in bariatric surgery: a systematic review. Obes Surg. 2013;23(8):1333–40. doi:10.1007/s11695-013-0913-3.
7. Foster MR. Rhabdomyolysis in lumbar spine surgery: a case report. Spine. 2003;28(14):E276–8.
8. Dakwar E, Rifkin SI, Volcan IJ, et al. Rhabdomyolysis and acute renal failure following minimally invasive spine surgery: report of 5 cases. J Neurosurg Spine. 2011;14(6):785–8. doi:10.3171/2011.2.SPINE10369.
9. Iser IC, Senkul T, Reddy PK. Major urologic surgery and rhabdomyolysis in two obese patients. Int J Urol: Off J Jpn Urol Assoc. 2003;10(10):558–60.
10. Karcher C, Dieterich HJ, Schroeder TH. Rhabdomyolysis in an obese patient after total knee arthroplasty. Br J Anaesth. 2006;97(6):822–4. doi:10.1093/bja/ael274.
11. Goodman SM, Figgie M, Green D, et al. Rhabdomyolysis is a potential complication of total hip arthroplasty in the morbidly obese. HSS J: Musculoskelet J Hosp Spec Surg. 2013;9(2):200–2. doi:10.1007/s11420-012-9310-z.
12. Youssef T, Abd-Elaal I, Zakaria G, et al. Bariatric surgery: rhabdomyolysis after open Roux-en-Y gastric bypass: a prospective study. Int J Surg. 2010;8(6):484–8. doi:10.1016/j.ijsu.2010.06.014.
13. Lagandre S, Arnalsteen L, Vallet B, et al. Predictive factors for rhabdomyolysis after bariatric surgery. Obes Surg. 2006;16(10):1365–70. doi:10.1381/096089206778663643.
14. Ettinger JE, de Souza CA, Santos-Filho PV, et al. Rhabdomyolysis: diagnosis and treatment in bariatric surgery. Obes Surg. 2007;17(4):525–32.
15. Pasternak RC, Smith Jr SC, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106(8):1024–8.
16. Voute MT, Winkel TA, Poldermans D. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery. Expert Opin Drug Saf. 2010;9(5):793–800. doi:10.1517/14740338.2010.499120.
17. Pereira SL, Stevermer JJ, Rowland K. Start a statin prior to vascular surgery. J Fam Pract. 2010;59(2):108–10.
18. Wool DB, Lemmens HJ, Brodsky JB, et al. Intraoperative fluid replacement and postoperative creatine phosphokinase levels in laparoscopic bariatric patients. Obes Surg. 2010;20(6):698–701. doi:10.1007/s11695-010-0092-4.
19. de Oliveira LD, Diniz MT, de Fatima HSDM, et al. Rhabdomyolysis after bariatric surgery by Roux-en-Y gastric bypass: a prospective study. Obes Surg. 2009;19(8):1102–7. doi:10.1007/s11695-008-9780-8.
20. Silecchia G, Rizzello M, Casella G, et al. Two-stage laparoscopic biliopancreatic diversion with duodenal switch as treatment of high-risk super-obese patients: analysis of complications. Surg Endosc. 2009;23(5):1032–7. doi:10.1007/s00464-008-0113-8.
21. Ettinger JE, Marcilio de Souza CA, Azaro E, et al. Clinical features of rhabdomyolysis after open and laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2008;18(6):635–43. doi:10.1007/s11695-007-9257-1.
22. Mulier JP, Dillemans B, Van Cauwenberge S. Impact of the patient’s body position on the intraabdominal workspace during laparoscopic surgery. Surg Endosc. 2010;24(6):1398–402. doi:10.1007/s00464-009-0785-8.